コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 king place during rotation of the CN bond in acetamide.
2 including acetamide enolate and O-protonated acetamide.
3 an methionine's side chain or the N-terminal acetamide.
4 under mild conditions without removal of the acetamide.
5 olysis of the nitrilium ion yielded N-benzyl acetamide.
6 ea, 1,3-dimethyl urea, 1,1-dimethyl urea and acetamide.
7 presence of small-molecule inducers, such as acetamide.
8 itude more stable than acetamidine, urea, or acetamide.
9 arboxylation of tryptophan to yield indole-3-acetamide.
10 hexanoic acid, and n-octane and 2-ethylhexyl acetamide.
11 from compounds where the N-substituents were acetamides.
12 with MeOH and EtOH affording formamides and acetamides.
13 onformation generally preferred by secondary acetamides.
14 )-5,7-dimethylpyrazolo[1,5-a]pyrimidin -3-yl)acetamide].
15 a potent and selective sPLA2 inhibitor, 3-(3-acetamide 1-benzyl-2-ethylindolyl-5-oxy)propanesulfonic
16 l-N-(2,4,6-trimethoxyphenyl)-2H-tetrazole-5- acetamide (1) was prepared and evaluated for their abili
17 sic agent (E)-2-(4,6-difluoro-1-indanylidene)acetamide, 1, has given rise to (E)-2-(4-chloro-6-fluoro
19 ted by the selective sPLA(2) inhibitors 3-(3-acetamide-1-benzyl-2-ethylindolyl-5-oxy)propane sulfonic
20 Using the selective sPLA(2) inhibitor 3-(3-acetamide-1-benzyl-2-ethylindolyl-5-oxy)propane sulfonic
21 14-kDa secretory phospholipase A(2) by 3-(3-acetamide-1-benzyl-2-ethylindolyl-5-oxy)propanephosphoni
23 3- or 4-aminophenyl)-2-(1-pyrrolidinyl)ethyl]acetamide (10 and 14) were prepared either without or wi
24 5,7-dimethyl-pyrazolo[1,5-a]pyrimidin-3- yl]-acetamide ((11)C-DPA-713), has been described that binds
25 )-5,7-dimethylpyrazolo[1,5-a]pyrim idin-3-yl)acetamide ((125)I-iodo-DPA-713) SPECT/CT or (18)F-FDG PE
26 (2S)-2-amino-2-substituted-N-(4-methylphenyl)acetamides 12a-d, easily prepared in two steps from N-Bo
27 rophenoxy)-N-(4-oxo-4H-3,1-benzothiazin-2-yl)acetamide (13), were identified as a novel class of pote
28 l-5-yl)-2-phenyl-N-(2,4,6-trimethoxypheny l) acetamide (13a) and (+/-)-2-(5-dodecylisoxazol-3-yl)-2-p
29 (2S)-2-amino-2-substituted-N-(4-nitrophenyl)acetamides 16a-c, succindialdehyde (13), and benzotriazo
30 l-3-yl)-2-phenyl-N-(2,4,6-trimethoxypheny l) acetamide (16a), were selected for further study and wer
31 1-yl)pyrimidin-4-yloxy)benzo[d] thiazol-2-yl)acetamide (16p), a potent TRPV1 antagonist [rTRPV1(CAP)
33 )-5,7-dimethylpyrazolo[1,5-a]pyri midin-3-yl)acetamide ((18)F-DPA-714) has been suggested to serve as
34 )-5,7-dimethylpyrazolo[1,5-a]pyri midin-3-yl)acetamide ((18)F-DPA-714), as a translational probe for
35 -1-yl)-N-(2,2,3,3,3-(18)F-pentafluoropropyl)-acetamide ((18)F-EF5) PET to monitor and predict tumor r
36 oxybenzyl)-2-(18)F-fluoro-N-(2-phenoxyphenyl)acetamide ((18)F-PBR06) for detecting alterations in tra
40 )-5,7-dimethylpyrazolo[1,5-a]pyrimidin- 3-yl)acetamide (2, DPA-714), were synthesized and biologicall
41 1-methylethyl)phenyl]-2,6-dioxo-7H-purine- 7-acetamide, 2-(1,3-dimethyl-2,6-dioxo-1,2,3,6-tetrahydro-
43 ino)-2-pyrimidinylthio-(N-beta-hydroxyethyl) acetamide (200 mg/kg) induced a wave of DNA synthesis in
44 ds for the synthesis of 7-substituted indole acetamides 3 and N-methyl (indol-7-yl)oxoacetates 6.
46 -4H-chromen-8-yl)dibenzo[b,d]th io-phen-1-yl)acetamide, 39; DNA-PK IC(5)(0) = 5.0 +/- 1 nM, IR dose m
47 -1-(3-aminophenyl)-2-(1-pyrrol idinyl) ethyl]acetamide (5) were synthesized and evaluated in mice for
48 drothiazol-5-yl}-N-(3-tr ifluoromethylphenyl)acetamide (5), showed a mixed-type inhibition pattern, w
49 5-b]pyridin-2-ylthio)-N-(3,4-dimethoxyphenyl)acetamide (5a) as a hit compound with a Ki value of 217
50 yl]-ethyl}-[1,3,4]thiadiaz ol-2-yl)-2-phenyl-acetamide 6, exhibited similar potency and better solubi
51 generate a C-3 quaternary carbon resulted in acetamide 6, which showed CCK-A receptor binding selecti
53 rifluoromethyl)phenyl)-N-(pyridin-3-ylmethyl)acetamide] (8-azaquinazolinone) without any basic group.
54 -2-(4-ethyl-6,6-dimethyl-2-oxomorpholin-3-yl)acetamide (87), which, in addition to fungicidal activit
55 zol-2-yl]-N-methyl-2-[4-(2-pyridinyl)phenyl ]acetamide, a helicase-primase inhibitor for the treatmen
56 enthalpies at the alpha carbons of acetone, acetamide, acetic acid, and acetyl fluoride, which were
58 Titration of the subcomplex with iodo[(14)C]acetamide after prolonged treatment with CuCl(2) in the
59 rahydro-7H-purin-7-yl)-N-(4-isopropylphenyl) acetamide) after its initial stimulation (and the calciu
60 osaminidase inhibition by an azetidine ADMDP-acetamide analogue is compared to an azetidine carboxyli
61 n the proline amides is found with the ADMDP-acetamide analogues bearing an acetamidomethylpyrrolidin
62 -5-oxo-3-vinyl-(1, 5-dihydropyrrol-2-ylidene)acetamide and 3-methyl-5-oxo-4-vinyl-(1, 5-dihydropyrrol
63 used to compute the CN rotation barriers for acetamide and eight related compounds, including acetami
64 oro-2,4-dimethoxyphenyl)-thioureido]-phenyl)-acetamide and its 2-fluoro-benzamide derivative inhibite
65 ent parameters (bis(trimethylsilyl)trifluoro-acetamide and sterol exposure time, sterol concentration
66 e aliquots were then treated with iodo[(14)C]acetamide and the incorporation of radioactivity was mea
67 drolysis of 1 with hydrochloric acid affords acetamide and the previously known diarylhydroxytelluron
68 -5-oxo-4-vinyl-(1, 5-dihydropyrrol-2-ylidene)acetamide and the third was 4-methyl-3-vinylmaleimide (M
69 to replace protecting groups with N-terminal acetamides and C-terminal methyl amides led to the intro
70 rise to a mixture of indanyl (or tetralinyl) acetamides and dehydrotetralins (or pallidols) (both or
71 The reaction of N-allyl-N-(2-halobenzyl)-acetamides and derivatives was investigated in liquid am
72 cological activities of a series of indole-3-acetamides and related compounds derived from this lead.
73 ons from a series of secondary N-(4-X-benzyl)acetamides and tertiary amides to the phthalimide-N-oxyl
76 onic spectra of formamide, N-methyformamide, acetamide, and N-methylacetamide at 300 K calculated usi
77 ent in potency over the best of the indole-3-acetamides, and LY315920 (6m) was selected for evaluatio
79 )-5,7-dimethylpyrazolo[1,5-a]py rimidin-3-yl)acetamide] and [(11)C]SSR180575 (7-chloro-N,N-dimethyl-5
80 des has been realized using N-(2-aminophenyl)acetamide (APA) as a new bidentate directing group for t
81 de and 2-(6-methylpyridin-2-yl)-N,N-diphenyl-acetamide are described along with results from the chem
85 s can be significantly enhanced by using the acetamide as a quasi-leaving group in a subsequent conve
87 otent and selective 2-amino-N-pyrimidin-4-yl acetamides as hA2A receptor antagonists with excellent a
89 gioselective palladium(II)-catalyzed primary acetamide assisted ortho arylation of arylacetamide has
91 of the conformational probe, methyl coumarin acetamide, attached specifically to the ryanodine recept
92 cular C-N and C-O cyclization of N-(biphenyl)acetamides based on the substituent electronic effects i
94 and S [N-(4-(3-acetamidophenyl)thiazol-2-yl-acetamide)] bind to CG and TA base pairs, respectively.
96 xylidino)-2-pyrimidinylthio (N-beta-hydroxyl)acetamide (BR931) alter hepatic sex steroid metabolism a
98 .8 x 10(-8) M(-1) s(-1) for deprotonation of acetamide by quinuclidine (pK(BH) = 11.5) and k(BH) = 2-
101 dendrimers in ascending order at pH 7.4 was: acetamide-capped, -NHC(O)CH3, neutral charge; carboxylic
102 attributed to chelate formation between the acetamide carbonyl group and the glycosidic oxygen in th
104 mer complex and the addition of the inducer, acetamide, causes a conformational change which alters t
105 5-bromofuran-2-yl)-4-oxo-4H-chromen-3-yl)oxy)acetamide (CB7993113), was further tested for its abilit
106 first report where functionalizable primary acetamide (-CH2CONH2) is used as a directing group for C
107 o[1,2-a]pyrimidin-9-yl)dibe nzothiophen-1-yl]acetamide) combined high potency against the target enzy
109 2-yl)-6-(trifluoromethyl)pyrimidin-2-ylt hio]acetamide (CP9), that binds to Hsp90(alpha/beta) and dis
112 tions of N-(cyclohex-2-enyl)-N-(2-iodophenyl)acetamides depend critically on the configurations of th
113 The AmiC.AmiR butyramide complex exhibits acetamide-dependent, sequence-specific RNA binding activ
114 9) and the C1 N-isopropyl-N-(4-methoxyphenyl)acetamide derivative of 3-(1H-Indazol-3ylmethyl)-3-methy
115 ydro)octafluoro[2.2]paracyclophane, from its acetamide derivative utilizing the Cadogan method led to
117 ctivating oximes, predominantly hydroxyimino acetamide derivatives (for hAChE) and imidazole-containi
118 reen, we identified 2-(2-oxo-morpholin-3-yl)-acetamide derivatives as fungicidal agents against Candi
119 bond in a series of N-cycloalkenyl-N-benzyl acetamide derivatives have been measured in different so
120 stitued piperazin-1-yl)-N-(4-sulfamoylphenyl)acetamide derivatives, showed low nanomolar inhibitory a
121 sertion of alpha-diazo-alpha-(phenylsulfonyl)acetamides derived from alpha-amino acids, which possess
122 The cis-directing effect was studied in N-acetamide dipeptoid model systems and evaluated in terms
123 -dimethylpyrazolo[1,5-alpha]pyrimi dine-3-yl)acetamide (DPA-714) is a radioligand for the 18-kDa tran
124 idazol-1-yl)-N-(2,2,3,3,3-pentafluoropropyl)-acetamide (EF5) allows for a comparative assessment of t
125 midazol-1-yl)-N-(2,2,3,3,3-pentafluoropropyl)acetamide (EF5) and beta-hCG and pimonidazole, two extri
126 midazol-1-yl)-N-(2,2,3,3,3-pentafluoropropyl)acetamide (EF5) was coadministered with the second one.
127 ole-1[H]-y1)-N-(2,2,3,3,3-pentafluoropropyl)-acetamide (EF5), we showed that the brain is hypoxic dur
128 henyl)sulfonyl]amino]-N-(3-pyridinyl methyl)-acetamide (EMPA), suppressed this effect, whereas a sele
132 to an activated state (high methyl coumarin acetamide fluorescence) as T-tubule depolarization did.
133 containing nucleotide gave rise to undesired acetamide formation resulting from nucleophilic attack o
134 , whereas the competitive inhibitor indole-3-acetamide fully protects the enzyme from inactivation.
136 potency of thiotetroamide C ascribed to the acetamide group and the unusual enzymology involved, we
139 he phenyl was para substituted with amine or acetamide groups, the NR1A/2B potency order was butynyl
140 6336 (6n-2), a hydroxy-substituted adamantyl acetamide, has been identified as a novel, potent inhibi
141 silylation employing N, O-bis(trimethylsilyl)acetamide, hexamethyldisilazane, and 1-(trimethylsilyl)i
143 (HBOA-d4) and 2-hydroxy-N-(2-hydroxyphenyl) acetamide (HHPAA-d4) were synthesized, to allow quantifi
146 dihydrophenanthridin-2-yl)(N,N-dimethylamino)acetamide hydrochloride (PJ34), using virtual screening;
147 -acetylglucosamine regioisomer the picolinyl-acetamide hydrogen bond persists and leads to an enhance
149 as acetic acid, benzoic acid, formaldehyde, acetamide, hydroxyacetic acid, oxoacetic acid, hydroxyac
150 eparation of dendrimers with terminal amino, acetamide, hydroxyl, and carboxylate groups was obtained
153 ts, in contrast to other aliphatic secondary acetamides in which significant E-rotamer populations ar
154 ucer of HEXIM1 expression, hexamethylene-bis-acetamide) in PyMT mice resulted in inhibition of metast
155 14 (2-(triethylamino)-N-(2,6-dimethylphenyl)-acetamide) induces internal pore blockade of single card
156 the mouse homolog of human hexamethylene bis-acetamide inducible-1 (HEXIM-1), regulates the pTEFb act
157 We report on the role of hexamethylene-bis-acetamide-inducible protein 1 (HEXIM1) as an inhibitor o
158 e previously reported that hexamethylene bis-acetamide-inducible protein 1 (HEXIM1) inhibits ERalpha
159 t the transcription factor Hexamethylene-bis-acetamide-inducible protein 1 (HEXIM1) is a tumor suppre
160 ass of compounds, 1,3-diaryl-[1H]-pyrazole-4-acetamides, initially identified from their ability to i
161 damine dimers form when tetramethylrhodamine acetamide is attached to two different sites in the N-te
162 he heteroatomic core of a pyrazolopyrimidine acetamide is sufficient to induce complex binding to wil
163 idazol-1-yl)-N-(2,2,3,3,3-pentafluoropropyl) acetamide] is such a drug, and it has been shown to be p
165 ensitive fluorescence probe, methyl coumarin acetamide (MCA), was incorporated into RyR in a protein-
166 hyl-N-(2-[1-pyrrolidinyl]cyclohexyl) benzene-acetamide methanesulfonate (U-50,488H; 1 microM), and ba
168 tamide, confirming specificity for the alkyl acetamide moiety and showing that the primary element of
173 ,2,4]-triazolo[1,5-c]quinazolin-5-yl]benzene acetamide (MRS1220) at the A(3) receptor and xanthine am
174 ere determined in D(2)O for deprotonation of acetamide, N,N-dimethylacetamide, and acetate anion by d
175 tly via the acetyl group with the oxygen and acetamide nitrogen hydrogen-bonded to the protein and th
176 upper side chain (proton donor) and glycine acetamide of the lower side chain (proton acceptor).
177 A regioselective oxidation of N-indan-4-yl-acetamide or N-(5,6,7,8-tetrahydronaphthalen-1-yl)acetam
178 3-(trifluoromethyl)-1H-pyrazol-1-yl]-phe nyl}acetamide (OSU-03012) killed primary human glioma and ot
179 3-(trifluoromethyl)-1H-pyrazol-1-yl]phenyl }-acetamide (OSU-03012) on both primary and glioblastoma c
180 3-(trifluoromethyl)-1H-pyrazol-1-yl]-phenyl} acetamide (OSU-03012), a previously characterized PDK1 i
182 of indole-based ligands characterized by an acetamide, oxalylamide, or carboxamide chain, respective
185 is of aqueous solutions of alpha-(methylthio)acetamide produced unexpectedly large quantities of acet
188 ammonium, nitrate, nitrite, urea, formamide/acetamide, purines, pyrimidines, polyamines, amino acids
189 5 mM 2(triethylamino-N-(2,6-dimethyl-phenyl)acetamide (QX-314) to block voltage-dependent Na+ curren
190 when 2(triethylamino)-N-(2,6-dimethylphenyl)acetamide (QX-314) was omitted from the recording pipett
192 ecular homolytic substitution, S(H)2, of the acetamide radical fragment by a H atom is the most likel
193 de produced unexpectedly large quantities of acetamide radicals that were identified by time-resolved
194 activation kinetics of the lead hydroxyimino acetamide reactivator of hAChE, when analyzed in terms o
195 rahydro-7H-purin-7-yl)-N-(4-isopropylphenyl )acetamide] reduces cold hypersensitivity in rodent model
196 ivatized to the corresponding thiourea and N-acetamides, respectively, and were quantified by positiv
197 leimide (SM), thiol-vinylsulfone (SV), thiol-acetamide (SA), penicillamine-thiol-maleimide (PM) or pe
198 ivity relationships of a lead pyrimidin-4-yl acetamide series to provide potent and selective 2-amino
199 yl-3,5-dihydro-4H-pyridazino[4 ,5-b]indole-1-acetamide), showed a significant binding in the lenti-CN
200 line68 in myoglobin has been replaced by the acetamide side chain of asparagine in an attempt to engi
201 achieved when one of the phenyl rings of the acetamide side chain was replaced with an alkyl group, p
203 roarylmethyl)piperazine 1a, benzamide 2, and acetamides such as 3a,b exhibit poor oral bioavailabilit
204 the 3-(2-phenethylamino)-6-methylpyrazinone acetamide template (e.g., 1) which resulted in the modif
205 ethylphenyl)-1H-1,2,4-triazol-3-yl]sulfanyl] acetamide (termed CK37) that inhibited purified recombin
206 tions with substrates (allyl GlcNAc, N-allyl acetamide) that were previously not possible for the cor
207 yl isocyanate, acetone, propionaldehyde, and acetamide-that had not previously been reported in comet
208 the chloroacetamide was fully reduced to an acetamide the pentasaccharides were obtained in four and
209 the key deficiency of noncovalent pyridinone acetamide thrombin inhibitor L-374,087 (1), namely, its
212 2-thiazolyl)-2-[(6-phenyl-3-pyridazinyl)thio]acetamide ] to investigate the influence of KCC2 functio
213 N-ethyl-2-(7-methyl-8-oxo-2-phenylpurin-9-yl)acetamide) to determine nondisplaceable distribution vol
214 ino)-2-pyrimidinylthio-(N-beta-hydroxyethyl) acetamide) to male wistar rats induced a wave of hepatoc
217 is described to access unsymmetrical diaryl acetamides under TM-free conditions from sec- and tert-a
219 usceptibility patterns, citrate utilization, acetamide utilization, and assimilation of inositol and
220 yl)phenyl)-N-(1-(5-methoxypyridin-2-yl)ethyl)acetamide], we demonstrated that polyunsaturated lipids,
221 arbony lamino]-2-(4-hydroxy-3-methoxyphenyl) acetamide), were further characterized in enzyme, cellul
223 in our previous paper, a series of indole-3-acetamides which possessed potency and selectivity as in
224 the auxins indole-3-acetic acid and indole-3-acetamide, which were produced by various (micro)algae s
225 [(E)-(5-hydroxy-1H-imidazol-2-yl)methylidene]acetamide, which, to our knowledge, has not been previou
226 had little or no incorporation of iodo[(14)C]acetamide, while the others that were treated with dithi
227 mide or N-(5,6,7,8-tetrahydronaphthalen-1-yl)acetamide with potassium permanganate followed by acidic
228 ontinued SAR development to produce indole-3-acetamides with additional functionalities which provide
229 yclohex-2-enyl)-N-(2-iodo-4,6-dimethylphenyl)acetamides with an additional ortho-methyl group did not
230 f alpha,alpha-difluoro-alpha-(trimethylsilyl)acetamides with aryl and heteroaryl bromides catalyzed b
231 lved the reaction of bis(ethylsulfenylacetyl)acetamides with dimethyl(methyl)thiosulfonium tetrafluor
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。